Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion type Assertion NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_head.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion description "[Because residual FAK protein in ISIS 15421-treated A549 cells was highly phosphorylated at the Tyr-397/Src homology (SH)2 binding site, expression of the FAK COOH-terminal domain (FRNK) was also used as an inhibitor of FAK function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_provenance.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion evidence source_evidence_literature NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_provenance.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion SIO_000772 11585739 NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_provenance.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion wasDerivedFrom befree-2016 NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_provenance.
- NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_assertion wasGeneratedBy ECO_0000203 NP331890.RAVgGtfFrYXRfgfjA1Pu8KOR8EIOV2vXH_vE0ZCY7fAGM130_provenance.